ad image

Company Info

Olon

Olon

CDMO

Overview

Olon is an Italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for the Generic market as well as in Contract Development and Manufacturing (CDMO). Headquartered in Rodano (Italy), Olon has 11 manufacturing facilities – 8 located in Italy, 1 in Spain, 1 in USA and 1 in India, all compliant with international requirements, and 3 branch offices. Olon offers complete integrated packages and services to support the full development of APIs based on strong knowledge in both, Chemical and Biological processes, in a full cGMPs environment including complete regulatory coverage. 
Olon
Contributions
29 Contributions1 / 2
Olon
Sustainability

Olon Releases its Annual ESG Report

Olon

PR-11-24-NI-110Dec 12, 2024
Olon
Biomanufacturing

Olon is Ready to Host Productions in the New Facility Dedicated to Ultra-Potent Compounds

Olon

PR-10-24-NI-72Nov 04, 2024
Olon
Financing

CPhI WW, Olon Will Attend with a Stronger Market Position after the Two International Acquisitions

Olon

PR-09-24-NI-23Sep 30, 2024
Olon
M&A

Olon Continues its Growth Path and Announces a New Acquistion

Olon

PR-09-24-NI-01Sep 04, 2024
Olon
High Potency API Suite

Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US

Olon

PR-M02-24-01Feb 05, 2024
Addressing the Evolving Nitrosamine Contamination Issue
Nitrosamine Impurities

Addressing the Evolving Nitrosamine Contamination Issue

Olon

PAO-09-23-CL-07Sep 15, 2023
Olon
Biocatalysis

Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme

Olon

PR-M05-23-02May 10, 2023
Olon
CDMO Leadership Award

Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards

Olon

PR-M03-23-04Mar 16, 2023
Olon
Academic Research

Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State

Olon

PR-M02-23-02Feb 21, 2023
Olon

Olon, International API Supplier, Releases New 2022 Sustainability Report

Olon

PR-M11-22-08Nov 22, 2022
Addressing Poor API Solubility with Comprehensive Particle Engineering Technology
Particle Engineering

Addressing Poor API Solubility with Comprehensive Particle Engineering Technology

Giorgio Bertolini, Ph.D.

Olon

PAO-11-022-CL-08Nov 18, 2022
Olon
High Containment

Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India

Olon

PR-M09-22-06Sep 27, 2022
Olon
Business Leadership

Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division

Olon

PR-M09-22-04Sep 19, 2022
Olon
New Division

Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes

Olon

PR-M07-22-03Jul 12, 2022
Driving Further Innovation by Integrating a Decentralized R&D Network
R&D

Driving Further Innovation by Integrating a Decentralized R&D Network

Giorgio Bertolini, Ph.D.

Olon

PAO-06-022-CL-02Jun 01, 2022
Olon
R&D

Olon Announces the Creation of a Major Center of Research and Development in Italy, That Will Give Rise to an Innovative Global R&D Model

Olon

PR-M05-22-10May 26, 2022
Olon
Spray Drying

Olon Invests in New Spray Dryer at Rodano R&D Centre

Olon

PR-M05-22-11May 17, 2022
Olon
API

CPhI Worldwide, A Significant Expansion of APIs Pipeline for Olon Group

Olon

PR-M11-21-02-780Nov 08, 2021
Olon
Expansion

Olon Group in Partnership With Aguettant Pharmaceutical Announces a Remarkable Expansion and Renovation of the Plant, Located in Mulazzano, Dedicated to Enzymatic Transformation

Olon

PR-M10-21-01Oct 28, 2021
Solving Complex Chemical Problems Across All Phases of NCE Programs
Complex Chemistry

Solving Complex Chemical Problems Across All Phases of NCE Programs

Luigi Trussardo

Olon

PAO-10-21-CL-11Oct 21, 2021
1 / 2